OBJECTIVE:To study the innovation system synergies of pharmaceutical manufacturing industry in Shanghai and lay the foundation for further enhancing the competitiveness of pharmaceutical enterprises of Shanghai. METHODS:Based on the composite system synergy degree model,order variables(G)of innovation environment(S1),innovation technology research and development(S2),innovation technology absorption(S3)and innovation output(S4)in the pharmaceutical manufacturing industry innovation system in Shanghai during 2006-2014 were selected,synergy degree model was built,and order parameter,order de-gree,synergy degree of each order variable were calculated in turn. RESULTS & CONCLUSIONS:S1-S4 obtained 4,4,4,2 or-der variables respectively. According to the calculation,synergy degree of pharmaceutical manufacturing industry in Shanghai dur-ing 2006-2014 ranged in -0.195-0.202,average value was -0.068,overall in the level of"inverse synergy"and"non-synergy". Thus,the internal development of the pharmaceutical manufacturing innovation system in Shanghai is more disorderly. It is suggest-ed to reform from the two core influencing factors of the stability of innovative environment and promoting technology absorption, including accelerating the transformation and upgrading of the pharmaceutical industry to create a stable and innovative environ-ment,increasing the innovation investment of the pharmaceutical industry to improve the level of technology absorption and inde-pendent innovation,as well as strengthening cooperation within and outside the domain to effectively enhance the system synergy degree level of pharmaceutical manufacturing innovation system in Shanghai.%目的:研究上海医药制造业产业创新系统的协同情况,为进一步提升上海医药企业的行业竞争力提供参考.方法:基于复合系统协同度模型,选取2006-2014年上海医药制造业创新系统的创新环境(S1)、创新技术研发(S2)、创新技术吸收(S3)以及创新产出(S4)四个子系统方面的序变量(G)设定协同度模型,依次计算各序变量的序参量、有序度及协同度.结果与结论:S1~S4分别得到4、4、4、2个序参量;2006-2014年上海市医药制造业的协同度在-0.195~0.202之间,平均值为-0.068,整体处于"逆协同"和"不协同"水平.可见,上海医药制造业创新系统内部发展状态较为无序,建议医药制造业从创新环境的稳定性和促进技术吸收这两个核心影响因素入手进行改革,包括加速医药产业转型升级,创造稳定创新环境;加大医药产业创新投入,提升技术吸收与自主创新水平;加强域内外合作交流等,切实提升上海医药制造业创新系统协同度水平.
展开▼
